Driven To Cure
It is with a heavy heart that we announce of the passing of Surevest client, Andrew Lee. He passed away Easter Sunday April 21st 2019 at age 23. Four years earlier he was diagnosed with a rare kidney cancer, hereditary leiomyomatosis and renal cell cancer (HLRCC), which currently has no known cure. Doctors told Andrew he may only have a year to live. With this news, Andrew and his family immediately looked for any new clinical trial which might help him. Andrew was referred to The National Institute of Health where research through clinical trials is having some success for HLRCC.
Andrew volunteered for 7 different experimental trials, sometimes being the first one to receive the new treatment. Andrew approached each clinical trial with a positive attitude. More incredible is what Andrew created during his short time; Driven To Cure.